• LAST PRICE
    1.4000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.2000/ 1
  • Ask / Lots
    1.6000/ 1
  • Open / Previous Close
    0.0000 / 1.4000
  • Day Range
    ---
  • 52 Week Range
    Low 1.2000
    High 98.5000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.41
TimeVolumeQNCX
09:32 ET13231.36
09:36 ET1501.34
09:38 ET16491.325
09:39 ET1001.3314
09:43 ET3881.3281
09:45 ET6001.3284
09:48 ET3501.3293
09:50 ET1001.3303
09:57 ET6481.35
10:03 ET25871.32
10:06 ET1001.32
10:14 ET5201.3299
10:15 ET7701.3
10:26 ET2141.3025
10:30 ET5001.3182
10:35 ET16691.32
10:39 ET1001.3
10:48 ET1001.32
10:50 ET2001.32
10:51 ET10001.34
10:53 ET3001.335
10:55 ET2001.35
10:57 ET1001.35
11:00 ET2001.35
11:02 ET89191.36
11:04 ET4811.3438
11:06 ET2001.37
11:08 ET3001.37
11:09 ET10001.37
11:11 ET2001.37
11:13 ET1001.37
11:18 ET2001.39
11:20 ET5001.39
11:22 ET1001.39
11:24 ET3001.39
11:26 ET1001.39
11:27 ET3001.39
11:29 ET2001.38
11:31 ET1001.38
11:33 ET2501.37
11:36 ET16951.36
11:42 ET1001.38
11:44 ET1001.38
11:45 ET2001.38
11:47 ET1001.38
11:54 ET1011.37
11:56 ET2001.39
11:58 ET2001.39
12:00 ET1001.39
12:02 ET3001.39
12:03 ET2001.39
12:05 ET2001.38
12:07 ET13001.39
12:09 ET1001.39
12:12 ET2001.39
12:14 ET1001.39
12:16 ET2001.39
12:18 ET8001.38
12:23 ET10301.38
12:34 ET1001.39
12:36 ET1001.39
12:38 ET1001.39
12:39 ET3001.39
12:41 ET1001.39
12:43 ET1001.39
12:45 ET1001.39
12:48 ET1001.39
12:50 ET3001.39
12:52 ET11001.39
12:54 ET1001.39
12:56 ET1001.39
12:57 ET4001.39
12:59 ET7001.39
01:01 ET3001.39
01:03 ET1001.39
01:06 ET4861.39
01:08 ET2001.39
01:10 ET1001.39
01:12 ET1001.39
01:14 ET2001.39
01:15 ET1001.39
01:17 ET2001.39
01:19 ET2001.39
01:21 ET1001.39
01:24 ET1001.39
01:26 ET2001.39
01:28 ET5001.38
01:30 ET1001.38
01:32 ET2001.38
01:33 ET2001.38
01:35 ET1001.38
01:37 ET6171.38
01:39 ET5041.37
01:44 ET4001.38
01:46 ET2001.38
01:48 ET2001.38
01:50 ET2001.38
01:51 ET1401.375
01:55 ET1001.38
02:00 ET1001.38
02:02 ET4001.38
02:04 ET3001.375
02:06 ET1001.375
02:08 ET2051.3794
02:09 ET3051.375
02:11 ET4001.38
02:13 ET3001.39
02:15 ET1001.39
02:18 ET1001.39
02:20 ET2001.38
02:22 ET1001.39
02:24 ET99001.39
02:26 ET1001.39
02:29 ET3001.39
02:31 ET10001.39
02:33 ET6001.39
02:36 ET3051.39
02:38 ET5001.39
02:40 ET3001.39
02:42 ET1001.39
02:44 ET3001.38
02:45 ET36151.4
02:47 ET3001.39
02:49 ET31821.37
02:54 ET1001.38
03:00 ET2001.3617
03:02 ET1001.38
03:03 ET4001.38
03:05 ET4001.38
03:07 ET1001.38
03:09 ET3001.38
03:12 ET10161.37
03:14 ET2501.36
03:16 ET5451.38
03:18 ET1001.38
03:20 ET6001.37
03:21 ET3001.375
03:23 ET2001.38
03:25 ET2001.375
03:27 ET4001.38
03:30 ET4001.38
03:32 ET9001.38
03:34 ET2001.38
03:36 ET3001.38
03:38 ET8001.38
03:39 ET4001.38
03:41 ET4001.38
03:43 ET4001.38
03:45 ET13001.38
03:48 ET4001.38
03:50 ET6501.38
03:52 ET8001.38
03:54 ET44791.38
03:56 ET3101.38
03:57 ET21351.39
03:59 ET38151.4
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesQNCX
Quince Therapeutics Inc
44.9M
-0.5x
---
United StatesNRXP
NRX Pharmaceuticals Inc
49.2M
-0.5x
---
United StatesAPLT
Applied Therapeutics Inc
45.6M
-0.2x
---
United StatesSNPX
Synaptogenix Inc
45.5M
-3.3x
---
United StatesAKTX
Akari Therapeutics PLC
40.9M
-1.7x
---
United StatesMBIO
Mustang Bio Inc
44.7M
-0.6x
---
As of 2022-09-30

Company Information

Quince Therapeutics, Inc., formerly Cortexyme, Inc., is a biopharmaceutical company. The Company is focused on advancing precision therapeutics targeting debilitating and rare diseases. The Company has discovered a bone-targeting drug platform capable of delivering small molecules, peptides, or large molecules directly to the site of broad bone fractures and disease designed to promote more healing with fewer off-target safety concerns. The Company’s lead compound, NOV004, is an anabolic peptide engineered to target and concentrate at the bone fracture site. Its discovery pipeline is focused on expanding across multiple skeletal therapeutic indications, including osteogenesis imperfecta, fractures, spinal fusion, and other severe diseases of bone such as cancer or infection. The Company's pipeline also includes legacy neuroscience and antiviral programs available for out-licensing, which include COR588, COR388, COR852 and COR803.

Contact Information

Headquarters
269 East Grand AveSOUTH SAN FRANCISCO, CA, United States 94080
Phone
415-910-5717
Fax
302-655-5049

Executives

Independent Chairman of the Board
David Lamond
Chief Executive Officer, Director
Dirk Thye
Principal Financial Officer
Ted Monohon
Chief Medical Officer
Karen Smith
Lead Independent Director
Una Ryan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$44.9M
Revenue (TTM)
$0.00
Shares Outstanding
35.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.36
EPS
$-2.74
Book Value
$3.94
P/E Ratio
-0.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.